Archivio Categoria: series A

ZSuite Tech Raises $11M in Series A Funding

USA – ZSuite Technologies, a Westwood, Mass.-based financial technology company that powers financial institutions with unbound digital accounts encompassing escrow, subaccounting, sub-ledgering, FBO and trust accounts for commercial customers, raised $11m in Series A funding. The round was led by S3 Ventures with participation from multiple private banks and JAM FINTOP. The company intends to use the funds […]

MarqVision Raises $20M in Series A Funding

USA – MarqVision, a Los Angeles, CA-based maker of an AI-powered platform designed to protect human creativity and innovation in a digital world, raised $20m in Series A funding. DST Global Partners and Atinum Investments joined previous investors Softbank Ventures, Bass Investment, and Y-Combinator. The company intends to use the funds to advance product development […]

Proof of Impact Raises $6M in Pre-Series A Funding

USA – Proof of Impact (POI), a San Diego, CA-based platform for ESG and impact data intelligence, raised $6m in Pre-Series A funding. The round was led by Rakuten Capital with participation from a global suite of investors including Franklin Templeton Blockchain Fund, Five T, Blockrocket VC and Advaita Capital, as well as existing investors Franklin […]

Savana Raises $45M in Series A Funding

USA – Savana, a Malvern, PA-based provider of financial software for banks and fintech companies, closed a $45m Series A funding. The round was led by Georgian with participation from Fiserv, a global provider of payments and financial services technology, which also will expand its existing reseller agreement with the company.The company intends to use the funds […]

IDRx Raises $122M in Series A Financing

USA – IDRx, Inc., a Plymouth, MA-based clinical-stage biopharmaceutical company dedicated to transforming cancer treatment with purpose-built precision combination therapies, raised $122m in Series A financing. The round was led by Andreessen Horowitz and Casdin Capital, with participation from Nextech Invest, Forge Life Science Partners and other undisclosed investors. Led by Ben Auspitz, co-founder and […]

GluBio Therapeutics Closes $22M Series A+ Financing

CHINA – GluBio Therapeutics, a San Diego, CA- and Shangai, China-based biotech company focused on developing novel targeted protein degradation (TPD) drugs, closed a $22m Series A+ financing. The round, which brought total capital raised to nearly $90m since its establishment in March, 2021, was led by Qiming Venture Partners with participation from Lilly Asia Ventures and […]

Leapfin Raises $12.2M in Series A Financing

USA – Leapfin, a San Francisco, CA-based provider of a Financial Data Management solution, raised $12.2M in Series A funding. The round was led by Crosslink Capital with participation from Work-Bench and Uncorrelated. Crosslink Partner Phil Boyer will join Leapfin’s Board of Directors. The company intends to use the funds to expedite product development, as […]

Ozette Raises $26M in Series A Funding

USA – Ozette Technologies, Inc., a Seattle, WA-based technology-driven life sciences startup engineering a transformative leap in cell discovery and annotation of the human immune system, raised $26M in Series A funding. The round was led by Madrona Ventures with participation from Cercano Management (formerly Vulcan Capital), M12, Microsoft’s venture fund, Alexandria Venture Investments, OCV […]

Fly.io Raises $12M in Series A; $25M in Series B 

USA – Fly.io, a Chicago, IL-based application delivery network company, raised $12M in Series A funding and $25M in Series B funding. The Series A funding was led by Intel Capital while Series B funding was led by Andreessen Horowitz. Other participants in the latest Series B round included Dell Technologies Capital, Initialized Capital, and […]

Vicinitas Therapeutics Raises $65M in Series A Financing

USA – Vicinitas Therapeutics, a South San Francisco, CA-based biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel therapeutics in cancer and genetic disorders, launched with $65m in Series A financing. The round was co-led by a16z and Deerfield Management, with participation from Droia Ventures, GV, The Mark Foundation for Cancer Research […]